Medication Error Rates
Contents |
to download it as a free PDF. Contents Chapter Page of 464 Original Pages Text Pages Get This Book «
Medication Error Statistics 2015
Previous: Appendix B Glossary of Terms and Acronyms Page 367 medication error rate calculation Share Cite Suggested Citation: "Appendix C Medication Errors: Incidence Rates ." Institute of Medicine. Preventing Medication Errors:
Medication Error Statistics 2014
Quality Chasm Series. Washington, DC: The National Academies Press, 2007. doi:10.17226/11623. × Save Cancel C Medication Errors: Incidence Rates This appendix reviews estimates of the rates of medication errors statistics medication errors and adverse drug events (ADEs) in three care settings (hospital, nursing home, and ambulatory care) and in pediatric and psychiatric care. Where possible, error rates for the five stages of the medication-use system and at the interface between care settings are documented separately. INCIDENCE OF MEDICATION ERRORS IN HOSPITAL CARE Selection and Procurement medication error definition of the Drug by the Pharmacy No studies were identified that specifically identified medication errors of this type. It is possible that these types of errors were included in studies of general medication error rates. Prescription and Selection of the Drug for the Patient: Errors of Commission Rates of prescribing errors (for example, dosing errors, prescribing medications to which the patient was allergic, prescribing inappropriate dosage forms) vary considerably from study to study and are quoted in several different ways—errors per 1,000 admissions, errors per 1,000 orders, errors per 100 opportunities for error, and preventable ADEs per 1,000 admissions (see Table C-1): Page 368 Share Cite Suggested Citation: "Appendix C Medication Errors: Incidence Rates ." Institute of Medicine. Preventing Medication Errors: Quality Chasm Series. Washington, DC: The National Academies Press, 2007. doi:10.17226/11623. × Save Cancel TABLE C-1 Hospital Care: Prescription and Selection Errors of Commission Error rates Per 1,000 admissions—detection method 12.3 (Lesar, 2002a)—pharmacist review of written orders 29 (Winterstein et al
is the definition of a medication error? What are the “ten key elements” of the medication-use system? Won’t medication errors
Medication Errors In Nursing
be prevented if nurses just follow the “Five Rights?” What are medication errors in hospitals statistics 2014 "high-alert" medications? What abbreviations are dangerous? Are these evidence based? What drug names are frequently confused?
Types Of Medication Errors
How should tall man lettering be applied to differentiate look-alike/sound-alike drug names? What is confirmation bias? How do I do an independent double check? How can I https://www.nap.edu/read/11623/chapter/15 measure culture? Should a healthcare practitioner be disciplined for being involved in an error? How can I assess risk? What is the difference between high-leverage and low-leverage safety strategies? What is an FMEA, and how can I use it? How do I join ISMP? What ISMP resources are available for consumers? Why are http://www.ismp.org/faq.asp standard concentrations safer than using the Rule of 6 for pediatric drips? What tools does ISMP have to satisfy regulatory or insurance network inclusion requirements for community pharmacies to demonstrate participation and knowledge in medication safe practices? Is there a way to get involved with ISMP as a student? Does ISMP have a nationally registered student-organization? 1. What is the national medication error rate? What standards are available for benchmarking? A national or other regional medication error rate does not exist. It is not possible to establish a national medication error rate or set a benchmark for medication error rates. Each hospital or organization is different. The rates that are tracked are a measure of the number of reports at a given institution not the actual number of events or the quality of the care given. Most systems for measuring medication errors rely on voluntary reporting of errors and near-miss events. Studies have shown that even in good systems,
Radiation-Emitting Products Vaccines, Blood & Biologics Animal & Veterinary Cosmetics Tobacco Products Drugs Home Drugs Drug Safety and http://www.fda.gov/Drugs/DrugSafety/MedicationErrors/ucm080629.htm Availability Medication Errors Section Contents Menu Drug Safety and Availability Medication Errors medication http://www.nccmerp.org/statement-medication-error-rates error reports Medication errors cause at least one death every day and injure approximately 1.3 million people annually in the United States. Medication mishaps can occur anywhere in the distribution system: prescribing, repackaging, dispensing, administering, or monitoring. Common causes of such errors include: poor communication, ambiguities in product names, directions for use, medication error medical abbreviations or writing, poor procedures or techniques, or patient misuse because of poor understanding of the directions for use of the product. In addition, job stress, lack of product knowledge or training, or similar labeling or packaging of a product may be the cause of, or contribute to, an actual or potential error. CDER began receiving reports of medication errors in January 1992, when the medication error statistics U.S. Pharmacopeia began forwarding reports to the FDA. To evaluate and recommend appropriate action on these reports, the Medication Errors Subcommittee was formed in June 1992. In November 1993, the Agency began evaluating and coding MedWatch reports for medication errors and publicly stated that physicians and other health care professionals could report medication errors directly to the FDA through the MedWatch program. CDER responsibilities are not completed when the safety and effectiveness of a drug product are determined. The Center also has the responsibility for helping to ensure the safe use of the drugs it approves by identifying and avoiding proprietary names that contribute to problems in the prescribing, dispensing, or administration of the product. Because early identification of a potential confusing proprietary name is crucial, CDER reviews these proposed names, prior to approval of a new drug application, by means of the Office of Postmarketing Drug Risk Assessment (OPDRA) CDER's approach to medication errors is as follows: Prevent medication errors prior to a drug's approval; After approval, evaluate, monitor, and take appropriate action on reports of medication errors; Educate and provide feedback to health professionals; and Share information with outside organizations involved i
Drug Event AlgorithmRecommendations / StatementsFor Consumers Statement on Medication Error Rates Statement from NCC MERP Use of Medication Error Rates to Compare Health Care Organizations is of No Value The use of medication error rates to compare health care organizations is not recommended for the following reasons: Differences in culture among health care organizations can lead to significant differences in the reporting of medication errors. Organizations that encourage medication error reporting by providing incentives and resources to report within a non-punitive, continuous quality improvement arena will likely report more medication errors than organizations that wish to conceal errors and punish individuals who are involved in or report errors. Differences in the definition of a medication error among health care organizations can lead to significant differences in the reporting and classification of medication errors. For example, some organizations may only consider actual errors that reach the patient as errors. Other organizations also will include potential errors and errors that do not reach the patient. The latter organizations will likely collect more medication errors, and information from reports of potential errors can sometimes be more useful in prevention efforts than reports of actual errors. Differences in the patient populations served by various health care organizations can lead to significant differences in the number and severity of medication errors occurring among organizations. For example, tertiary care hospitals generally may serve more severely ill patients than rehabilitation hospitals. In addition, the intensity of drug therapies, the types of drugs used, and the methods of drug distribution may be substantially different in these environments, the